Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma.
Nalee KimDo Hoon LimJung Won ChoiJung-Il LeeDoo-Sik KongHo Jun SeolDo Hyun NamPublished in: Yonsei medical journal (2023)
HypoRT with 58.5 Gy in 25 fractions could provide comparable oncologic outcomes and significantly reduce the ALC changes. In addition, HypoRT decreased the LDT. Further investigation should be warranted to suggest the significance of reduced LDT through HypoRT affecting survival outcomes.